Profile
AKU DHR-PB TMO DHR IQV A
Company Name Akumin Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $26.27M $916.76B $231.76B $197.82B $43.69B $40.06B
Employees 1.74K 79.00K 122.00K 61.00K 88.00K 17.60K
CEO Mr. Riadh Zine-El-Abidine Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
AKU DHR-PB TMO DHR IQV A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
AKU DHR-PB TMO DHR IQV A
Last Close $0.2887 $1261.26 $607.14 $273.91 $239.67 $137.32
High 52 $0.36 $1261.26 $607.14 $273.91 $259.1 $154.64
Low 52 $0.13 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High -19.81 % 0 % 0 % 0 % -7.5 % -11.2 %
Price vs. 52 Week Low 122.08 % 0 % 40.73 % 47.98 % 35.28 % 35.73 %
Total Return
AKU DHR-PB TMO DHR IQV A
1 Month Return 0 % 0 % 10.23 % 8.8 % 12.65 % 4.98 %
3 Month Return 0 % 0 % 5.85 % 11.08 % 2.04 % -0.3 %
6 Month Return 0 % 0 % 10.93 % 17.56 % 10.91 % 4.83 %
9 Month Return 0 % 0 % 40.73 % 45.79 % 33.19 % 33.62 %
YTD Return 0 % 0 % 14.38 % 18.4 % 3.58 % -1.23 %
1 Year Return 49.9 % 0 % 8.41 % 7.3 % 6.73 % 8.42 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AKU DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.38 % 0.24 % 0.38 % - 0.68 %
Dividend Paid and Capex Coverage Ration (TTM) 1.53 % 3.16 % 4.82 % 2.53 % 3.98 % 3.02 %
Dividend Per Share (TTM) - 1.05 % 1.48 % 1.05 % - 0.93 %
Payout Ratio (TTM) - 17.87 % 8.91 % 28.62 % - 21.74 %
Growth
AKU DHR-PB TMO DHR IQV A
Asset Growth -8.01 % 0.16 % 1.62 % 0.16 % 5.3 % 2.35 %
Gross Profit Growth 130.27 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth 78.03 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year 125.3 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year 152.52 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year 1130.97 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth 218.64 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -335.42 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share -1403.08 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share -533.33 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share -3090.62 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth 218.64 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) 283.38 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 144.78 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 302.31 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 3845.62 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth -275.56 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth -275.56 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -139.36 % 5.14 % 7.9 % 5.14 % 8.21 % 12.39 %
Share Holder 3 Year Equity Growth Per Share -125.84 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -123.12 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -771.43 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % - 7.8 %
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % - 25.46 %
Dividend 5 Year Growth Per Share - 173.92 % 104.77 % 173.92 % - 51.49 %
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % - 97.03 %
Debt Growth 2.75 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth 2622.03 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
AKU DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 17.61 % 58.45 % 40.3 % 59.41 % 29.7 % 50.71 %
Return on Assets TTM -13.75 % 5.33 % 6.33 % 5.35 % 5.39 % 11.44 %
Return on Equity TTM 283 % 8.42 % 13.48 % 8.04 % 22.79 % 20.87 %
Return on Capital Employed TTM -2.28 % 7.39 % 8.76 % 6.21 % 10.68 % 14.65 %
Net Income Per EBT TTM 105.08 % 83.98 % 90.86 % 99.88 % 94.99 % 93.45 %
EBT Per Ebit TTM 641.49 % 94.74 % 93.52 % 94.37 % 70.93 % 101.92 %
EBIT Per Revenue TTM -4.49 % 21.3 % 17.32 % 21.13 % 13.9 % 19.78 %
Cash Flow To Debt Ratio TTM 4.19 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Receivables Turnover TTM 6.42 7.76 5.33 6.4 4.61 5.28
Payables Turnover TTM 14.06 6.49 - 5.21 3.23 7.05
Inventory Turnover TTM 72.28 4.12 4.86 3.21 - 3.25
Fixed Asset Turnover TTM 209.88 % 463.28 % 456.22 % 367.49 % 1979.04 % 429.94 %
Asset Turnover TTM 45.46 % 31.45 % 42.99 % 26.87 % 57.58 % 60.71 %
Operating Cash Flow Per Share TTM 0.69 9.27 24.47 8.74 13.39 6.47
Free Cash Flow Per Share TTM 0.24 7.39 20.85 6.92 10.03 5.25
Cash Per Share TTM 41.95 % 937.04 % 2309.69 % 321.85 % 920.97 % 570.31 %
Operating Cash Flow Sales Ratio TTM 8.37 % 26.52 % 22.08 % 30.55 % 16.05 % 28.77 %
Free Cash Flow Operating Cash Flow Ratio TTM 34.52 % 79.76 % 85.18 % 79.14 % 74.88 % 81.12 %
Cash Flow Coverage Ratios TTM 4.19 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Price To Free Cash Flows Ratio TTM 1.22 35.66 29.1 38.77 23.91 26.05
Price To Operating Cash Flows Ratio TTM 0.42 29.55 24.81 31.34 17.9 21.22
Price Cash Flow Ratio TTM 0.42 29.55 24.81 31.34 17.9 21.22
Income Statement (TTM)
AKU DHR-PB TMO DHR IQV A
Revenue $0.75B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $0.14B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 18.84% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $0.14B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.15B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -1.69 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
AKU DHR-PB TMO DHR IQV A
Long Term Debt $1.43B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $1.62B $31B $51.88B $31B $20.57B $4.92B
Total Equity $-0.05B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $1.48B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $1.77B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
AKU DHR-PB TMO DHR IQV A
Net Income $-0.15B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $0B $-0.27B
Operating Cash Flow $0.07B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0.04B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 137.32
ACRS Aclaris Therapeutics, Inc. 1.39
APDN Applied DNA Sciences, Inc. 0.4101
AWH Aspira Women's Health Inc. 1.49
BDSX Biodesix, Inc. 1.72
BIAF bioAffinity Technologies, Inc. 2.71
BIAFW bioAffinity Technologies, Inc. 0.55
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.627
BNR Burning Rock Biotech Limited 6.38
CDNA CareDx, Inc 19.01
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.01
CNTG Centogene N.V. 0.34
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 233.47
CSTL Castle Biosciences, Inc. 21.06
DGX Quest Diagnostics Incorporated 145.59
DHR Danaher Corporation 273.91
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to AKU
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.69
IWC iShares Micro-Cap ETF 0.00006 129.25
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000311065 92.7
Unlock